Target Audience: Psychiatrists, Primary Care Physicians, Pharmacists, Psychologists, Nurse Practitioners, Psychiatric Nurses, and Social Workers
This virtual conference will feature international experts on depression, anxiety, schizophrenia, and evolving approaches to the psychiatric impacts of COVID-19. And as always, we will offer local expertise on other important topics in psychopharmacology. Participants will be able to interact with the speakers via a live Q&A board, with lots of time for audience questions.
Agenda and a list of keynote speakers are available on the event web page.